Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
出版年份 2014 全文链接
标题
Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
作者
关键词
-
出版物
Molecular Oncology
Volume 8, Issue 8, Pages 1379-1392
出版商
Wiley
发表日期
2014-05-29
DOI
10.1016/j.molonc.2014.05.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acetylation of FoxO1 Activates Bim Expression to Induce Apoptosis in Response to Histone Deacetylase Inhibitor Depsipeptide Treatment
- (2015) Yang Yang et al. NEOPLASIA
- MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
- (2013) A. R. Chakraborty et al. BLOOD
- Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
- (2013) L. Amiri-Kordestani et al. CLINICAL CANCER RESEARCH
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- The pan-histone deacetylase inhibitor CR2408 disrupts cell cycle progression, diminishes proliferation and causes apoptosis in multiple myeloma cells
- (2011) Philipp Baumann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
- (2011) Vitaliy O. Kaminskyy et al. CARCINOGENESIS
- Vorinostat-Induced Apoptosis in Mantle Cell Lymphoma Is Mediated by Acetylation of Proapoptotic BH3-Only Gene Promoters
- (2011) S. Xargay-Torrent et al. CLINICAL CANCER RESEARCH
- Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
- (2011) B. Venugopal et al. CURRENT MEDICINAL CHEMISTRY
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy
- (2011) M Gupta et al. LEUKEMIA
- Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
- (2011) Robert W. Robey et al. MOLECULAR PHARMACEUTICS
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance
- (2010) Wenlin Shao et al. INTERNATIONAL JOURNAL OF CANCER
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
- (2009) Susan E. Bates et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic Modifiers: Basic Understanding and Clinical Development
- (2009) R. L. Piekarz et al. CLINICAL CANCER RESEARCH
- Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
- (2009) D. Palmieri et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1
- (2009) S. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression
- (2009) C.-C. Yeh et al. MOLECULAR CANCER THERAPEUTICS
- Finding the place of histone deacetylase inhibitors in prostate cancer therapy
- (2009) Deborah L Marrocco-Tallarigo et al. Expert Review of Clinical Pharmacology
- Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A
- (2008) Simon J. Crabb et al. BIOCHEMICAL PHARMACOLOGY
- Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
- (2008) A. Newbold et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now